CPI 2025 China Pharmaceutical Industry Conference – Hainan Station to Open Next Thursday with Confirmed Participation from Livzon Pharma, Qilu Pharma, China Resources Pharma, Federal Pharma, and Jianjin Pharma
Qilu Pharmaceutical
Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer
Conference Name | CPI 2025 China Pharmaceutical Industry Conference · Hainan Station
Sign-in Time |October 30-31, 2025, 8:00 AM - Registration Begins
Check-in Location |Zhouzhi Luxe Select Haikou Yacht Hotel
(Please wear your attendee badge after completing the check-in. It is your only valid credential for the event. Keep it safe as it will not be replaced if lost.)
Small amountFreeSeat
09:00-09:40
China's Drug Central Procurement Policy Adjustment Reshapes the Future of the Pharmaceutical Industry
Geng HongwuExecutive Deputy Director of the Medical Health Research Center, Old Science and Technology Association, Tsinghua University
09:40-10:20
Interpretation of the Policy on Changes to Marketed Drugs
Zhu MingDirector of the Pharmaceutical Chemistry Review Department, Hainan Provincial Center for Drug and Medical Device Evaluation and Review Services
10:20-10:25
High-Quality Approval/Project Release
10:25-10:45
A Moment of Relaxation
10:45-11:25
Analysis of Regulatory Policies for Drug Contract Manufacturing Under New Regulations
Long ZhengjunFormer Second-Class Inspector of Shaanxi Provincial Drug Administration
11:25-12:05
In-depth Implementation of GMP for Pharmaceuticals and Analysis of Common Defects
Yuan ZhiHainan Province Drug Inspection Center Drug Inspector
Scan the QR code to register immediately
14:00-14:30
Current Status and Reflections on China's Drug Exports
Chen YongfaProfessor at China Pharmaceutical University
14:30-15:00
Global Clinical and Registration Launch - Practical Case Sharing
Hui AiminFounder, Chairman and CEO of Huizhengqi Medicine, Former Executive President of Fosun Pharma
15:00-15:05
High-Quality Approval/Project Release
15:05-15:25
A Moment of Relaxation
15:25-15:55
Considerations for the Internationalization of Sterile Preparations
Song QingguoVice President of Jianjin Pharmaceutical
15:55-16:25
Discussion on the Internationalization Path of Formulations and Sharing of Common Issues
Meng XiaofengCo-President of HaiChang Biotech
16:25-16:55
Opportunities and Challenges for Chinese Pharmaceutical Companies in Commercial Overseas Expansion —— Case Sharing of Platform-based Overseas Collaboration
He ShehuiSenior Director of Kexing Pharmaceutical Expansion Center
Scan to register immediately
09:00-09:30
Key Points and Common Issues in the Construction of Quality Management Systems for Contract Manufacturing
Xie HaiyanGeneral Manager of Quality Management Headquarters, Livzon Pharmaceutical Group
09:30-10:00
Technology Transfer in Pharmaceutical Production - Analysis of Common Issues in Drug Registration
Teacher WangFormer Zhejiang Province Pharmaceutical Supervision Expert, National GMP Inspector
10:00-10:30
High-Quality Approval/Project Release
10:30-10:50
A Moment of Relaxation
10:50-11:20
Key Points for Drug Data Integrity Verification
Hu MiaoFormer Head of the National Drug Production Inspection Team
11:20-11:50
MAH's Path to Quality Compliance: Anchors and Challenges in Contract Manufacturing Quality Compliance
Huang YuedongChief Audit Officer of Changzhou Siyao Pharmaceutical Co., Ltd.
14:00-14:40
Discussion on Quality Research Strategies for Post-Market Drug Changes
Liu FengDirector of the Chemical Drug Testing Institute, Sichuan Provincial Institute for Drug Control
14:40-15:20
Key Points and Common Issues in Pharmacovigilance Inspections Under the New Regulations
Miao HuiqingDeputy Director of Hainan Provincial Pharmacovigilance Center
15:20-16:00
Considerations for Pharmaceutical Process Validation under the GMP Compliance Framework
Tang DaoshengNational GMP Inspector, Registration Verification Officer
Scan to register immediately
09:00-09:30
Reflections on the Breakthrough Development Direction for Pure B-License Enterprises
Diancang CraneFounder of Pharmaceutical Cloud Studio, well-known expert in pharmaceutical market access and marketing models, and compliance consulting
09:30-10:00
Risk Control and Compliance Practices in Cleaning Validation for Shared-Line Production
Zhang XinExpert Committee Member of the Pharmaceutical Technology Special Committee of the China Pharmaceutical Education Association; Senior Engineer in Pharmaceutical Engineering, Six Sigma Black Belt
10:00-10:30
High-Quality Approval Documents / Project Release
10:30-10:50
A Moment of Relaxation
10:50-11:20
Drug Registration Verification Procedures and Key Focus Areas
Teacher TianFormer Deputy Chairman of the Academic Committee, Chief Pharmacist, and Expert-Level Inspector of the National Medical Products Administration Verification Center
11:20-11:50
Analysis of Misunderstandings and Management Breakthroughs in Technology Transfer
Wu Jun Pharmaceutical Manufacturing Systems Engineering and GMP Expert
14:00-14:40
Product Launch Directions and Strategies for Marketing Authorization Holders
Zhao Zhongwei General Manager of Shenzhen Aoqi Biomedical Co., Ltd.
14:40-15:20
Selection and Daily Management of CMO
Ye FeiQuality Director of Shenzhen CR&JX Pharmaceutical Co., Ltd.
15:20-16:00
Regulatory Requirements and Common Issues for Drug Manufacturing B/C Certificates
Liu DefuDirector of Quality, Federal Pharmaceutical Group
Scan the code to register immediately
09:00-09:30
Risk Analysis in the Process of Pharmaceutical Quality Control Testing
Peng JifengFormer Director of Shantou Institute for Drug Control in Guangdong Province, National Drug (GMP) Inspector, and Guangdong Provincial Drug Evaluation Expert
09:30-10:00
Latest Regulatory Trends and Inspection Requirements for Pharmaceutical Water Systems in China
Zhang GongchenInvited Expert for the Pharmacopoeial Water Standards System of the 2020 and 2025 Editions of the Chinese Pharmacopoeia by the National Pharmacopoeia Commission
10:00-10:15
Analysis and Testing of Key Consumables Helps Improve Quality and Efficiency in the Pharmaceutical Industry
Wu GangGeneral Manager of Shanghai Anpu Experimental Technology Co., Ltd.
10:15-10:30
High-Quality Approval Documents / Project Release
10:30-10:50
A Moment of Relaxation
10:50-11:20
Laboratory OOS Investigation
Liu Weiqiang Former Deputy Minister of GMP at the Certification and Evaluation Center of the Shanghai Food and Drug Administration, Former Senior GMP Inspector at the National Food and Drug Administration
11:20-11:50
Compliance Requirements and Overview of Liquid Sterilizing Filtration Process Validation
Peng Ying Head of Merck Process Solutions Validation Laboratory
14:00-14:40
Overview of New Guidelines in the Microbial Contamination Control System of the 2025 Edition of the Chinese Pharmacopoeia
Lin Liying Former Director of the Microbiology Department at Guangdong Provincial Institute for Drug Control
14:40-15:20
Interpretation of the Guiding Principles for Analytical Method Validation in the 2025 Edition of the Chinese Pharmacopoeia
Yang Weifeng Former Deputy Director of the Chemical Medicine Department, Zhejiang Provincial Institute for Food and Drug Control, Chief Pharmacist
15:20-16:00
Analysis of the Main Content of the General Notices of Part II of the 2025 Edition of the Chinese Pharmacopoeia
Liu HaijingChief Expert of Shaanxi Institute for Food and Drug Control
Scan to register immediately
The conference opens several booths:
More on-site booths are being booked火热ly, offering various promotional opportunities for CRO/CDMO/instrument equipment suppliers/consulting service companies: forum hosting, keynote speeches, venue booths, project roadshows, standing screen displays, conference publication color pages,挂牌s, promotional materials bags, dinner冠名, notebooks, tea break sponsorships, etc.
For more details on business cooperation benefits, fee standards, etc., please inquire:
Ms. Wang 13588474548
Ms. Zhou 15858667450
Ms. Zhang 15005862516
Ms. Cao 15520811395
Ms. Zhou 13983785571
Participants
1. Chairman, General Manager, and other decision-makers of pharmaceutical enterprises;
2. R&D, project initiation, clinical directors, managers, researchers, and other personnel in pharmaceutical enterprises;
3. Head of pharmaceutical R&D institution;
4. Head of the Clinical Trial Institution;
5. Person in charge related to MAH B Certificate enterprises;
6. Personnel from drug safety evaluation agencies and drug development consulting agencies;
7. Pharmaceutical company QA/QC/production/registration personnel;
8. Personnel engaged in drug research in pharmaceutical research institutes, drug inspection units, and pharmaceutical colleges and universities;
9. Business BD Leader;
10. Relevant personnel from investment institutions;
Registration
Registration: ConferenceFree for a Limited Time(Limited number of participants, first come first served. This registration is a pre-registration. Successful registration will be confirmed after the review is passed!) Accommodation and meals are at your own expense.
Registration Consultation for Participation:
Ms. Cui 13018913819 (Same number on WeChat)
Mr. Qi 17280026948 (Same number on WeChat)
Ms. Wen 18868801402 (Same for WeChat)
Scan the code to register for free attendance
